share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  09/03 18:07

Moomoo AI 已提取核心訊息

Pfizer Inc. (PFE) has reported a significant transaction by Chairman & CEO Albert Bourla. The transaction, which took place on 08/30/2024, involved Bourla dealing with non-derivative securities of the company. However, the specific details regarding the number of shares, nature of the shares, transaction price, and the total value of the shares were not disclosed in the announcement. The action reflects a notable change in Bourla's holdings in Pfizer, but without the complete data, the impact on his total share ownership remains unclear.
Pfizer Inc. (PFE) has reported a significant transaction by Chairman & CEO Albert Bourla. The transaction, which took place on 08/30/2024, involved Bourla dealing with non-derivative securities of the company. However, the specific details regarding the number of shares, nature of the shares, transaction price, and the total value of the shares were not disclosed in the announcement. The action reflects a notable change in Bourla's holdings in Pfizer, but without the complete data, the impact on his total share ownership remains unclear.
輝瑞藥業公司(PFE)董事長兼CEO阿爾伯特·博樂進行了一項重要交易。該交易發生在2024年08月30日,涉及博樂與公司的非衍生證券打交道。然而,公告中沒有披露關於股票數量、股票性質、交易價格和股票總價值的具體細節。這一舉措反映了博樂在輝瑞的持股有重大變化,但由於缺乏完整數據,對他的總股權的影響仍不明確。
輝瑞藥業公司(PFE)董事長兼CEO阿爾伯特·博樂進行了一項重要交易。該交易發生在2024年08月30日,涉及博樂與公司的非衍生證券打交道。然而,公告中沒有披露關於股票數量、股票性質、交易價格和股票總價值的具體細節。這一舉措反映了博樂在輝瑞的持股有重大變化,但由於缺乏完整數據,對他的總股權的影響仍不明確。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息